Impact of treatment on long-term visual function in retinal vein occlusion-response to the comment on: retinal vein occlusion and the use of a dexamethasone intravitreal implant (Ozurdex®) in its treatment.
Swiss Eye Institute and Berner Augenklinik am Lindenhofspital, University of Bern, Bern, Switzerland. garweg@swiss-eye-institute.com.
Justus G
JG
Garweg
Swiss Eye Institute and Berner Augenklinik am Lindenhofspital, University of Bern, Bern, Switzerland.
Souska
S
Zandi
D003907:Dexamethasone; D004343:Drug Implants; D005938:Glucocorticoids; D006801:Humans; D058449:Intravitreal Injections; D008269:Macular Edema; D012170:Retinal Vein Occlusion; D014792:Visual Acuity
D004343:Drug Implants; D005938:Glucocorticoids; D003907:Dexamethasone